🧑🚀LAAO, Houston we have a problem!
Rocío Parrilla @rociomd8 - Sección de Cardiología Intervencionista Hospital Universitario de Jaen.
🎬Edited by: @RumoJose , @foroic & @pipecardio.
How many would like to learn how to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in #TAVI? here
a very useful problem-solving step-by-step tutorial. a patient-centered learning for free and accessible to everyone. @PCRonline@escardio@akiko704@kiadeb87@TCTMD@crfheart@secardiologia@shci_sec
https://t.co/P6cF9bOoGg
📌 Habemos nuevas Guías 📖 de Valvulopatías 🇪🇺 en #ESCCongress
📝¿Qué hay de nuevo?
✏️Hilazo 🧵 de los principales cambios desde mi pt de vista 👇👇👇
✅Y por supuesto enorme 👏 a @RosselloXavier y la gran Esther Pérez-David (mi adjunta 😊) por la contribución 🇪🇸
🚨 Breaking News from #ESCCongress:
The 2025 ESC/EACTS Guidelines on Valvular Heart Disease are out!
Key updates:
🫀 Heart Teams & advanced imaging central to diagnosis & treatment
🫀 #TAVI extended to ≥70y anatomically suitable tricuspid AS pts, regardless of surgical risk
🫀 New Class IIa: early intervention in asymptomatic severe high-gradient AS
🫀 New Class I: early surgical repair for asymptomatic severe primary MR
🫀 TEER upgraded:
✔ Class IIa for high-risk primary MR
✔ Class I for HF + severe secondary MR with LVEF <50%
🫀 Stronger role for tricuspid surgery & emerging TTVI for high-risk pts
🫀 Updated antithrombotic & valve dysfunction recommendations
🫀 New sections: cancer + VHD, acute HF, multiple/mixed VHD, and sex-specific management
📖 Full text in @ESC_Journals:
👉 🔗https://t.co/l64WB6HZBh
#VHD #CardioX #ESC2025 #EACTS
🔥 First-in-human report: Treatment t of a coronary bifurcation core perforation with dual covered stents!
Take-home
🥽 Prepare in the wet lab
🫀 Complex PCI techniques can be needed in ACS patients
🚨 Stepwise bifurcation treatment was key!
https://t.co/GXmlWxJBzC
ROLLER COASTR-EPIC22: Rotational atherectomy, lithotripsy, or laser for calcified coronary stenosis
🔗https://t.co/bXY4yH4R3I
Read this #EAPCI/PCR Journal Club review ✍️of the first randomised trial comparing RA, IVL, and ELCA for calcified coronary lesions, by @aayshacader and @ANazmiCalik.
#calcifiedlesions #CHIP #interventionalcardiology #JournalClub
📌Por último, cobra mucha importancia el INOCA (la angina con coronarias "normales")
📝 Cuidado, el orden importa. Primero detectamos isquemia, después tratamos, si persisten síntomas estudiamos la micro
📝Se mojan en protocolo (@egutiMD crack)
📝 Se mojan en tratamiento 🆕
🙋♂️ ¿Cirugía (CABG 🔪) o ICP (🎈 🗑 )?
Pues depende de 3 factores
📝 Complejidad anatómica. A mayor complejidad, +🔪
📝 Diabetes: +🔪
📝 Riesgo QX. Aspecto a mi juicio fundamental dado que mayormente tratamos pacientes
Esta figura de guías de GPC revascularización, la biblia 👇
📌¿Y por qué es importante la probabilidad pre-test?
🙋♂️Pues porque determina qué prueba diagnóstica y pronóstica tienes que hacer
Paso 3: CONFIRMACIÓN
✅ <5%: Nada más. Descartamos
✅ 5-85%: Give me something more
✅ >85%: Cateterismo
Buenísima y clarificadora figura 👇👇👇
After years… we have finally been able to summarize all the tricks we endorsed or developed… Indeed, we STRONGLY BELIEVE that the benefit of transcatheter procedures like #PCI#Impella#ECMO#TAVR often depends on how we deal with the arterial access!!! Thank you to the TEAM!
This state-of-the-art review provides a description of the device-related thrombotic risk associated with transcatheter structural heart interventions and of the current evidence-based guidelines regarding antithrombotic treatments. Gaps in evidence for each of the studied transcatheter interventions and the main ongoing trials are also summarised. https://t.co/b4Kx4DAyDP